A. Corral

发表

Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

E. Poveda, J. Benito, V. Soriano, 2007, Journal of medical virology.

Characterization of seven genotypes (A to E, G and H) of Hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1 (p 24-32)

M. Akashi, Katsuaki Sato, X. Wang, 2005 .

Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS.

Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.

V. Soriano, C. de Mendoza, A. Corral, 2005, AIDS patient care and STDs.

Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

V. Soriano, C. de Mendoza, A. Corral, 2009, Antimicrobial Agents and Chemotherapy.

Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

V. Soriano, C. de Mendoza, A. Corral, 2009, Journal of Clinical Microbiology.

Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.

W. Heneine, C. de Mendoza, A. Corral, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

W. Heneine, C. de Mendoza, A. Corral, 2007, AIDS.

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

B. Rodés, V. Soriano, M. Johnson, 2005, AIDS.

Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance

V. Soriano, C. de Mendoza, A. Corral, 2008, AIDS.

Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations

V. Soriano, C. de Mendoza, A. Corral, 2004, AIDS.

Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals.

V. Soriano, C. de Mendoza, A. Corral, 2004, Journal of virological methods.

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

E. Poveda, V. Soriano, C. de Mendoza, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.

V. Soriano, C. de Mendoza, A. Corral, 2007, AIDS research and human retroviruses.

Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues

V. Soriano, A. Corral, C. Mendoza, 2004, AIDS.

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.

V. Soriano, J. Eiros, J. Torre-Cisneros, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

V. Soriano, A. Corral, J. González-lahoz, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High rate of resistance to antiretroviral drugs among HIV-infected prison inmates.

V. Soriano, C. de Mendoza, A. Corral, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.

V. Soriano, J. del Romero, C. de Mendoza, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

B. Rodés, V. Soriano, C. de Mendoza, 2002, AIDS research and human retroviruses.

Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

V. Soriano, C. de Mendoza, A. Corral, 2003, Journal of Clinical Microbiology.

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

V. Soriano, J. del Romero, C. de Mendoza, 2002, AIDS.

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

V. Soriano, J. Eiros, J. Torre-Cisneros, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Relationship between drug resistance mutations, plasma viremia, and CD4+ T‐cell counts in patients with chronic HIV infection

V. Soriano, C. de Mendoza, A. Corral, 2005, Journal of medical virology.

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

E. Poveda, V. Soriano, E. Seclén, 2010, AIDS.

Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals.

V. Soriano, C. Briones, A. Corral, 2000, Journal of acquired immune deficiency syndromes.

Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

L. Bacheler, V. Soriano, T. Pattery, 2006, AIDS.

Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS Research and Human Retroviruses.

Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

E. Poveda, V. Soriano, N. Parkin, 2008, AIDS.

Europe and Asia

E. Poveda, V. Soriano, C. de Mendoza, 2022 .

Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells.

J. Benito, V. Soriano, A. Corral, 2012, AIDS research and human retroviruses.

Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir.

V. Soriano, C. de Mendoza, A. Corral, 2002, Clinical Infectious Diseases.

Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations

V. Soriano, A. Corral, I. Jiménez-Nácher, 2004, AIDS.

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.

E. Poveda, V. Soriano, C. de Mendoza, 2009, AIDS research and human retroviruses.

Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

V. Soriano, C. de Mendoza, A. Corral, 2009, Antimicrobial Agents and Chemotherapy.

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

E. Poveda, V. Soriano, C. de Mendoza, 2008, Clinical Infectious Diseases.

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.

E. Poveda, V. Soriano, V. Briz, 2007, The Journal of antimicrobial chemotherapy.

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

B. Rodés, V. Soriano, C. de Mendoza, 2002, AIDS research and human retroviruses.